Is fluorometric sentinel lymph node biopsy in endometrial cancer necessary?

被引:0
|
作者
Huang, Liqiong [1 ]
Cheng, Wei [2 ]
He, Chenghui [1 ]
Li, Xin [2 ]
Huang, Lu [2 ]
Zhang, Jiajia [2 ]
Song, Liwen [1 ]
Zhou, Yifan [1 ]
Wang, Chenchen [3 ]
Gan, Xiaoqin [2 ]
Qiu, Jin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China
[2] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Dept Obstet & Gynecol, Chengdu, Sichuan, Peoples R China
[3] Shanghai United Family Pudong Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
endometrial cancer; SLNB; case-control study; prognosis; surgery; LYMPHADENECTOMY; METASTASIS;
D O I
10.3389/fmed.2024.1434311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective In this study, we collected perioperative and postoperative follow-up data from patients with endometrial cancer (EC) at different stages to evaluate the role of sentinel lymph node biopsy (SLNB) in endometrial cancer surgery.Methods A total of 186 endometrial cancer patients undergoing radical hysterectomy from January 2018 to April 2022 were retrospectively analyzed. Patients were classified into four groups. Group A comprised patients diagnosed with stage IA grade 1 and 2 endometrioid EC who underwent SLNB. Group B comprised patients with stage IA grade 1 and 2 endometrioid EC who did not undergo SLNB. Group C comprised patients with higher-grade endometrioid EC, wherein systematic lymph node dissection was performed based on SLNB results. Group D comprised patients with higher-grade endometrioid EC who did not undergo SLNB and instead underwent direct systematic lymph node dissection. Clinical, pathological data, and follow-up information for all patients were collected.Results In Group A and B, SLNB was performed on 36 out of 67 patients with IA stage 1 and 2 endometrial cancer, yielding a SLN positivity rate of 5.6%. There were no significant differences observed between the two groups regarding perioperative outcomes and postoperative follow-up. Conversely, among 119 patients with higher-grade endometrial cancer, 52 underwent SLNB, with 20 patients exhibiting SLN positivity, resulting in a SLN positivity rate of 38.4%. However, the decision to undergo SLNB did not yield significant differences in perioperative outcomes and postoperative follow-up among these patients.Conclusion For stage IA grade 1 and 2 endometrioid EC, the incidence of lymph node positivity is low, omitting SLNB in this subpopulation is a feasible option. In other stages of endometrioid EC, there is no significant difference in perioperative and postoperative follow-up data between patients undergoing routine systematic lymphadenectomy and those undergoing systematic lymphadenectomy based on SLNB results. Therefore, if SLNB is not available, the standard procedure of PLND remains an option to obtain information about lymph node status, despite the surgical complications associated with this procedure.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Enlarged para-sentinel lymph node dissection is not necessary in breast cancer patients undergoing sentinel lymph node biopsy
    Li, Xiaoyan
    Kong, Xiaoli
    Chen, Sisi
    Jiang, Liyu
    Ma, Tingting
    Yang, Qifeng
    BREAST JOURNAL, 2019, 25 (05): : 1025 - 1028
  • [22] Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma, Cervical Cancer, and Endometrial Cancer
    Zivanovic, Oliver
    Khoury-Collado, Fady
    Abu-Rustum, Nadeem R.
    Gemignani, Mary L.
    ONCOLOGIST, 2009, 14 (07): : 695 - 705
  • [23] Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
    Wang, Bo
    Xue, Yu
    Wang, Qian
    Xu, Yan
    Chen, Xiaojun
    Wang, Chao
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (174):
  • [24] Validation Study Of Sentinel Lymph Node Biopsy In The Staging And Treatment Of Endometrial Cancer
    Patrut, D.
    Alors Ruiz, J.
    Sanchez Urbaneja, I.
    Rahmouni, O.
    Oliva Pastor, J.
    Sanz Viedma, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S233 - S233
  • [25] Sentinel lymph node biopsy in endometrial cancer in early stages: evaluation of results
    Cordero Garcia, J.
    de la Manzanara Cano, C. Lopez
    Palomar Munoz, A.
    Talavera Rubio, M.
    Tello Galan, M.
    Poblete Garcia, V.
    Pena Pardo, F.
    Garcia Vicente, A.
    Soriano Castrejon, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S286 - S286
  • [26] Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients
    Maggiore, Umberto Leone Roberti
    Bascio, Ludovica Spano
    Alboni, Carlo
    Chiarello, Giulia
    Savelli, Luca
    Bogani, Giorgio
    Martinelli, Fabio
    Chiappa, Valentina
    Ditto, Antonino
    Raspagliesi, Francesco
    EJSO, 2024, 50 (03):
  • [27] Single port robotic sentinel lymph node biopsy and hysterectomy in endometrial cancer
    Sinno, A. K.
    Fader, A. Nickles
    Scheib, S.
    Tanner, E. J., III
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 9 - 10
  • [28] The utilisation of sentinel lymph node biopsy for endometrial cancer in Australia and New Zealand
    Foster, Leon
    Burling, Michael
    Brand, Alison
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2022, 62 (01): : 104 - 109
  • [29] Preliminary results of the application of sentinel lymph node biopsy (SLNB) in endometrial cancer
    Asadurova, S.
    Fuertes, S.
    Villasboas, D.
    Navales, I.
    Cardozo, A.
    Cabrera, S.
    Menendez, S.
    Bellviure, R.
    Velazquez, F.
    Echeverri, J.
    Aguade, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S295 - S295
  • [30] Sentinel lymph node biopsy in endometrial and cervical cancer: current and controversial issues
    Tantitamit, T.
    Huang, K-G
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (06) : 919 - 924